Drug Shortage Report for ERWINASE

Last updated on 2018-05-26 History
Report ID 47317
Drug Identification Number 02237815
Brand name ERWINASE
Common or Proper name Erwaina L-asparaginase
Company Name JAZZ PHARMACEUTICALS FRANCE SAS
Market Status CANCELLED POST MARKET
Active Ingredient(s) ASPARAGINASE
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 3 mL vials, 5 vials per carton
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-04-23
Estimated end date
Actual end date 2018-05-25
Shortage status Resolved
Updated date 2018-05-26
Company comments Unexpected delays in release of the next batch of the product
Health Canada comments
Contact Address 84 QUAI CHARLES DE GAULLE CITY ONE
LYON, AUVERGNE-RHONE-ALPES
FRANCE 69006
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2018-05-26 English Compare
v11 2018-05-25 French Compare
v10 2018-05-25 English Compare
v9 2018-05-25 French Compare
v8 2018-05-25 French Compare
v7 2018-05-25 English Compare
v6 2018-05-25 English Compare
v5 2018-05-24 French Compare
v4 2018-05-24 English Compare
v3 2018-05-24 English Compare
v2 2018-04-27 French Compare
v1 2018-04-27 English Compare